An overview of antibacterial drug classes, including their mechanisms of action, spectrum of activity, clinical uses, and important considerations such as resistance and stewardship.
Understanding the pharmacology of antibacterial agents requires a firm grasp of microbiology and the specific ways drugs interact with bacterial structures. Antibiotics are generally categorized by their mechanism of action (how they kill or inhibit bacteria) and their microbial spectrum (the range of bacteria they can target).
Structural differences between Gram-positive and Gram-negative bacteria.
Before diving into specific classes, it is essential to distinguish between bacterial types. Gram-positive bacteria lack an outer membrane and stain easily, while Gram-negative bacteria possess an outer membrane and are often more pathogenic. Furthermore, aerobic bacteria are often easier to treat because they reside in well-circulated areas, whereas anaerobic bacteria thrive in oxygen-poor, poorly circulated environments, making drug distribution more challenging.
Mechanisms of Action and Efficacy
Antibiotics are classified by their physiological effect on the bacteria:
Bactericidal: These agents cause direct bacterial cell death. This includes drugs that impair the cell wall, disrupt the cell membrane, or inhibit DNA/RNA synthesis.
Bacteriostatic: These agents inhibit growth and replication, allowing the host's immune system to eventually eradicate the pathogen. Most protein synthesis inhibitors (except aminoglycosides) fall into this category.
The four primary mechanisms of action are:
Cell Wall Impairment: Creating holes in the cell wall so the cell lyses as it grows.
Protein Synthesis Inhibition: Targeting the bacterial ribosome to stop protein production.
DNA Synthesis Inhibition: Generating metabolites that cause DNA strand breakage.
Folic Acid Synthesis Inhibition: Blocking the production of folic acid, which is essential for nucleic acid synthesis.
Beta-Lactam Antibiotics
The beta-lactam group is one of the most significant classes in clinical practice, characterized by a specific chemical ring structure.
Penicillins and Beta-Lactamase Inhibitors
Mechanism of beta-lactamase inhibitors protecting penicillin.
Penicillins interfere with cell wall synthesis. While natural penicillins are narrow-spectrum and susceptible to the enzyme beta-lactamase (which inactivates the drug), newer generations are broader and more resistant. To combat resistance, Beta-lactamase Inhibitor Combinations (such as clavulanic acid, sulbactam, or tazobactam) are used. These inhibitors bind to the bacterial enzyme, preventing it from destroying the penicillin ring.
Clinical Pearl: Always ask about penicillin allergies. There is a 3–10% cross-allergy risk with Cephalosporins.
Cephalosporins
Classified into "generations," cephalosporins increase in spectrum as they progress from 1st to 5th generation.
3rd/4th Gen: Broad spectrum, including Gram-negative and CNS coverage.
Pharmacokinetics: Most are excreted by the kidneys, though Ceftriaxone is excreted by the liver.
Monobactams and Carbapenems
Monobactams (Aztreonam): Unique because they only target aerobic Gram-negative bacteria.
Carbapenems: The broadest spectrum available. They are used for multi-drug resistant organisms and polymicrobial infections. However, they must be used judiciously to prevent resistance.
Protein Synthesis Inhibitors
These drugs target the bacterial ribosome to stop the production of essential proteins.
Macrolides and Ketolides
Macrolides (e.g., Erythromycin, Azithromycin) and Ketolides (e.g., Telithromycin) are generally bacteriostatic. They are highly effective against "atypical" bacteria like Chlamydia and Legionella, as well as H. pylori.
Adverse Effects: A major concern is QTc prolongation, which can lead to dangerous arrhythmias like Torsades de pointes.
Aminoglycosides
Unlike most protein synthesis inhibitors, aminoglycosides (e.g., Gentamicin) are bactericidal. They are used for serious Gram-negative infections, often in combination with cell-wall inhibitors.
Toxicity Warning: They are notorious for ototoxicity (irreversible hearing loss/tinnitus) and nephrotoxicity (reversible kidney damage).
Tetracyclines
Tetracyclines (e.g., Doxycycline) are broad-spectrum and bacteriostatic. They are used for acne, Lyme disease, and Rickettsia.
Contraindications: They must be avoided in children under 8 years old, pregnant women, and breastfeeding mothers due to risks of tooth discoloration and skeletal growth depression.
Lincosamides (Clindamycin)
Clindamycin is particularly effective against anaerobic bacteria and Gram-positive cocci. A significant adverse effect is the risk of Clostridium difficile colitis due to the disruption of normal gut flora.
DNA and Folic Acid Inhibitors
Fluoroquinolones
Fluoroquinolones (e.g., Ciprofloxacin, Levofloxacin) are broad-spectrum bactericidal agents that inhibit DNA synthesis. They are often used for respiratory infections or nosocomial pneumonia.
Black Box Warnings/Risks: They can cause tendon rupture (especially the Achilles tendon) and should be avoided in children and pregnant women.
Sulfonamides
Sulfonamides (e.g., Trimethoprim-Sulfamethoxazole) inhibit folic acid synthesis. They are commonly used for UTIs and P. jiroveci pneumonia.
Emergency Alert: A rare but life-threatening adverse effect is Stevens-Johnson Syndrome (SJS), which presents as a vesicular oral rash progressing to full-body skin desquamation.
Metronidazole
Metronidazole is a bactericidal agent that inhibits bacterial DNA production. It is the drug of choice for anaerobic infections and certain protozoal infections.
Interaction: Patients must avoid alcohol to prevent a disulfiram-like reaction (flushing, nausea, tachycardia).
Specialized and Miscellaneous Agents
Glycopeptides (Vancomycin): Bactericidal agents that impair cell wall synthesis. Vancomycin is the first-line treatment for MRSA. It requires monitoring of "peak and trough" levels to prevent toxicity.
Oxazolidinones (Linezolid): Synthetic agents used for resistant Gram-positive pathogens.
Lipopeptides (Daptomycin): Used for multidrug-resistant Gram-positive bloodstream infections.
Principles of Antibiotic Stewardship
Antibiotic stewardship is the practice of guarding against inappropriate use to reduce drug resistance. Resistance occurs through bacterial mutation or gene transfer.
To combat this, clinicians should:
Obtain cultures before starting antibiotics.
Avoid using antibiotics for viral infections (e.g., common colds).
Ensure patients complete the full prescribed regimen.
Choose the most appropriate dose and duration based on the infection site, severity, and host factors.
Exam Tip: When interpreting sensitivity results, remember that MIC (Minimum Inhibitory Concentration) is the lowest concentration of an antibiotic that inhibits bacterial growth. A smaller MIC indicates a more potent effect against that specific organism.
Keep reading for free.
Create an account to finish this reading and make it part of your study routine.
